Pancreatic Cancer Research

ResearcherXi'an Jiaotong UniversityNo recent work listed

Lei Cao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9676-7366; OpenAlex author ID A5076710062. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2015: 1 paper · 2016: 4 papers · 2017: none · 2018: 1 paper · 2019: 1 paper

Papers 7

  1. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways. Last author DOI 10.3892/or.2018.6833↗
  2. Curcumin inhibits superoxide dismutase-induced epithelial-to-mesenchymal transition via the PI3K/Akt/NF-κB pathway in pancreatic cancer cells. Last author DOI 10.3892/ijo.2018.4295↗
  3. Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathw… Co-author DOI 10.3892/ijo.2016.3559↗
  4. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway. First author DOI 10.3892/or.2015.4504↗
  5. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway. Co-author DOI 10.3892/or.2016.4709↗
  6. Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway. Co-author DOI 10.3892/or.2016.5044↗
  7. Superoxide dismutase promotes the epithelial-mesenchymal transition of pancreatic cancer cells via activation of the H2O2/ERK/NF-κB axis. First author DOI 10.3892/ijo.2015.2938↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qingyong Ma · 6 shared papers, 2015–2019 · strength 0.48
  2. Wěi Li · 4 shared papers, 2015–2019 · strength 0.32
  3. Wei Li · 2 shared papers, 2016–2018 · strength 0.17
  4. Jianjun Lei · 2 shared papers, 2016 · strength 0.15
  5. Liang Han · 1 shared paper, 2019 · strength 0.11
  6. Zheng Wang · 1 shared paper, 2019 · strength 0.11
  7. Zheng Wang · 1 shared paper, 2018 · strength 0.09
  8. Zheng Wu · 1 shared paper, 2018 · strength 0.09
  9. Zhengdong Jiang · 1 shared paper, 2018 · strength 0.09
  10. Wei Li · 1 shared paper, 2016 · strength 0.08
  11. Jiangbo Liu · 1 shared paper, 2016 · strength 0.08
  12. Lun Zhang · 1 shared paper, 2016 · strength 0.08
  13. Wanxing Duan · 1 shared paper, 2016 · strength 0.07
  14. Liang Han · 1 shared paper, 2015 · strength 0.06
  15. Qinhong Xu · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.